ns 1619 and cyclic gmp

ns 1619 has been researched along with cyclic gmp in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (60.00)18.2507
2000's1 (20.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Armstead, WM2
Bryan, RM; Pelligrino, DA; Wang, Q1
Brakemeier, S; Eichler, I; Fassheber, T; Hoyer, J; Knorr, A; Köhler, R1
Angulo, J; Chen, M; Cuevas, P; Fernández, A; González-Corrochano, R; La Fuente, J; Sáenz de Tejada, I1

Other Studies

5 other study(ies) available for ns 1619 and cyclic gmp

ArticleYear
Role of activation of calcium-sensitive K+ channels in NO- and hypoxia-induced pial artery vasodilation.
    The American journal of physiology, 1997, Volume: 272, Issue:4 Pt 2

    Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Animals, Newborn; Arterioles; Benzimidazoles; Benzopyrans; Cerebral Arteries; Cromakalim; Cyclic GMP; Female; Hypoxia; Male; Muscle, Smooth, Vascular; Nitric Oxide; Nitroprusside; Penicillamine; Pia Mater; Potassium Channels; Pyrroles; S-Nitroso-N-Acetylpenicillamine; Swine; Vasodilation; Vasodilator Agents

1997
Calcium-dependent and ATP-sensitive potassium channels and the 'permissive' function of cyclic GMP in hypercapnia-induced pial arteriolar relaxation.
    Brain research, 1998, May-18, Volume: 793, Issue:1-2

    Topics: Adenosine Triphosphate; Animals; Benzimidazoles; Blood Pressure; Calcium; Carbon Dioxide; Cerebral Arteries; Cromakalim; Cyclic GMP; Glyburide; Hydrogen-Ion Concentration; Hypercapnia; Indazoles; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Penicillamine; Peptides; Pia Mater; Potassium Channel Blockers; Potassium Channels; Rats; Rats, Sprague-Dawley; Substrate Specificity; Vasodilation

1998
Contribution of kca channel activation to hypoxic cerebrovasodilation does not involve NO.
    Brain research, 1998, Jul-13, Volume: 799, Issue:1

    Topics: Animals; Arteries; Benzimidazoles; Cerebrovascular Circulation; Cyclic GMP; Endorphins; Enzyme Inhibitors; Female; Hypoxia; Intermediate-Conductance Calcium-Activated Potassium Channels; Male; Nitric Oxide; Nitroarginine; Pia Mater; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Calcium-Activated; Swine; Vasodilation

1998
Modulation of Ca2+-activated K+ channel in renal artery endothelium in situ by nitric oxide and reactive oxygen species.
    Kidney international, 2003, Volume: 64, Issue:1

    Topics: Animals; Benzimidazoles; Bradykinin; Cyclic GMP; Drug Combinations; Endothelium, Vascular; Large-Conductance Calcium-Activated Potassium Channels; Nitric Oxide; Nitric Oxide Donors; Patch-Clamp Techniques; Potassium Channels, Calcium-Activated; Reactive Oxygen Species; Renal Artery; Swine; Vasodilation

2003
Ca2+ -activated K+ channel (KCa) stimulation improves relaxant capacity of PDE5 inhibitors in human penile arteries and recovers the reduced efficacy of PDE5 inhibition in diabetic erectile dysfunction.
    British journal of pharmacology, 2013, Volume: 169, Issue:2

    Topics: Adult; Aged; Animals; Benzimidazoles; Carbolines; Cyclic GMP; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Electric Stimulation Therapy; Erectile Dysfunction; Humans; Male; Middle Aged; Nitric Oxide; Penis; Phosphodiesterase 5 Inhibitors; Piperazines; Potassium Channels, Calcium-Activated; Purines; Rats; Rats, Sprague-Dawley; Sildenafil Citrate; Sulfones; Tadalafil; Vasodilation; Vasodilator Agents

2013